APO Research
Talk to an analyst

APO RESEARCH · REPORT

Meropenem Injection

Compare research editions
View pricing & licenses

Selected research

Industry Research

Meropenem Injection Industry Research Report 2026

2 January 2026151 pages

Choose your research edition.

Industry ResearchMeropenem Injection Industry Research Report 2026151 pages · $2,950 USDIndustry Growth & TrendsGlobal Meropenem Injection Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Meropenem Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Meropenem Injection Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Meropenem Injection Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Meropenem Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Meropenem Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Meropenem Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Meropenem Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Meropenem Injection include Chongqin Shenghuaxi, Zhejiang Hisun Pharmaceutical, Xinya Pharm, CSPC Group, Shenzhen Haibin Pharmaceutical, Sandoz, Mylan, Luoxin Pharmaceutical and United Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Meropenem Injection market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Meropenem Injection Market by Company

Chongqin Shenghuaxi

Zhejiang Hisun Pharmaceutical

Xinya Pharm

CSPC Group

Shenzhen Haibin Pharmaceutical

Sandoz

Mylan

Luoxin Pharmaceutical

United Laboratories

Pfizer

Hainan Haiyao Co., Ltd.

Fresenius Kabi

PKU HealthCare

Sumitomo Dainippon Pharma

Sagent Pharmaceuticals

Macleods Pharmaceuticals

Johnlee Pharmaceuticals

Bionova Scientific

AuroMedics

Amneal Pharmaceuticals

Meropenem Injection Segment by Type

0.25g/vial

0.5g/vial

1g/vial

Meropenem Injection Segment by Application

Hospital

Clinics

Others

Meropenem Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Meropenem Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Meropenem Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Meropenem Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Meropenem Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Meropenem Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Meropenem Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Meropenem Injection Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Meropenem Injection Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Meropenem Injection Sales Market Share by Manufacturers (2021-2026) Table 8. Global Meropenem Injection Revenue of Manufacturers (2021-2026) Table 9. Global Meropenem Injection Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Meropenem Injection Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Meropenem Injection Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Meropenem Injection, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Meropenem Injection, Product Type & Application Table 14. Global Meropenem Injection Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Meropenem Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Chongqin Shenghuaxi Company Information Table 19. Chongqin Shenghuaxi Business Overview Table 20. Chongqin Shenghuaxi Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Chongqin Shenghuaxi Meropenem Injection Product Portfolio Table 22. Chongqin Shenghuaxi Recent Developments Table 23. Zhejiang Hisun Pharmaceutical Company Information Table 24. Zhejiang Hisun Pharmaceutical Business Overview Table 25. Zhejiang Hisun Pharmaceutical Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Zhejiang Hisun Pharmaceutical Meropenem Injection Product Portfolio Table 27. Zhejiang Hisun Pharmaceutical Recent Developments Table 28. Xinya Pharm Company Information Table 29. Xinya Pharm Business Overview Table 30. Xinya Pharm Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Xinya Pharm Meropenem Injection Product Portfolio Table 32. Xinya Pharm Recent Developments Table 33. CSPC Group Company Information Table 34. CSPC Group Business Overview Table 35. CSPC Group Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. CSPC Group Meropenem Injection Product Portfolio Table 37. CSPC Group Recent Developments Table 38. Shenzhen Haibin Pharmaceutical Company Information Table 39. Shenzhen Haibin Pharmaceutical Business Overview Table 40. Shenzhen Haibin Pharmaceutical Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Shenzhen Haibin Pharmaceutical Meropenem Injection Product Portfolio Table 42. Shenzhen Haibin Pharmaceutical Recent Developments Table 43. Sandoz Company Information Table 44. Sandoz Business Overview Table 45. Sandoz Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Sandoz Meropenem Injection Product Portfolio Table 47. Sandoz Recent Developments Table 48. Mylan Company Information Table 49. Mylan Business Overview Table 50. Mylan Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Mylan Meropenem Injection Product Portfolio Table 52. Mylan Recent Developments Table 53. Luoxin Pharmaceutical Company Information Table 54. Luoxin Pharmaceutical Business Overview Table 55. Luoxin Pharmaceutical Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Luoxin Pharmaceutical Meropenem Injection Product Portfolio Table 57. Luoxin Pharmaceutical Recent Developments Table 58. United Laboratories Company Information Table 59. United Laboratories Business Overview Table 60. United Laboratories Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. United Laboratories Meropenem Injection Product Portfolio Table 62. United Laboratories Recent Developments Table 63. Pfizer Company Information Table 64. Pfizer Business Overview Table 65. Pfizer Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Pfizer Meropenem Injection Product Portfolio Table 67. Pfizer Recent Developments Table 68. Hainan Haiyao Co., Ltd. Company Information Table 69. Hainan Haiyao Co., Ltd. Business Overview Table 70. Hainan Haiyao Co., Ltd. Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Hainan Haiyao Co., Ltd. Meropenem Injection Product Portfolio Table 72. Hainan Haiyao Co., Ltd. Recent Developments Table 73. Fresenius Kabi Company Information Table 74. Fresenius Kabi Business Overview Table 75. Fresenius Kabi Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Fresenius Kabi Meropenem Injection Product Portfolio Table 77. Fresenius Kabi Recent Developments Table 78. PKU HealthCare Company Information Table 79. PKU HealthCare Business Overview Table 80. PKU HealthCare Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. PKU HealthCare Meropenem Injection Product Portfolio Table 82. PKU HealthCare Recent Developments Table 83. Sumitomo Dainippon Pharma Company Information Table 84. Sumitomo Dainippon Pharma Business Overview Table 85. Sumitomo Dainippon Pharma Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Sumitomo Dainippon Pharma Meropenem Injection Product Portfolio Table 87. Sumitomo Dainippon Pharma Recent Developments Table 88. Sagent Pharmaceuticals Company Information Table 89. Sagent Pharmaceuticals Business Overview Table 90. Sagent Pharmaceuticals Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Sagent Pharmaceuticals Meropenem Injection Product Portfolio Table 92. Sagent Pharmaceuticals Recent Developments Table 93. Macleods Pharmaceuticals Company Information Table 94. Macleods Pharmaceuticals Business Overview Table 95. Macleods Pharmaceuticals Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Macleods Pharmaceuticals Meropenem Injection Product Portfolio Table 97. Macleods Pharmaceuticals Recent Developments Table 98. Johnlee Pharmaceuticals Company Information Table 99. Johnlee Pharmaceuticals Business Overview Table 100. Johnlee Pharmaceuticals Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Johnlee Pharmaceuticals Meropenem Injection Product Portfolio Table 102. Johnlee Pharmaceuticals Recent Developments Table 103. Bionova Scientific Company Information Table 104. Bionova Scientific Business Overview Table 105. Bionova Scientific Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Bionova Scientific Meropenem Injection Product Portfolio Table 107. Bionova Scientific Recent Developments Table 108. AuroMedics Company Information Table 109. AuroMedics Business Overview Table 110. AuroMedics Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. AuroMedics Meropenem Injection Product Portfolio Table 112. AuroMedics Recent Developments Table 113. Amneal Pharmaceuticals Company Information Table 114. Amneal Pharmaceuticals Business Overview Table 115. Amneal Pharmaceuticals Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Amneal Pharmaceuticals Meropenem Injection Product Portfolio Table 117. Amneal Pharmaceuticals Recent Developments Table 118. Global Meropenem Injection Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 119. Global Meropenem Injection Sales by Region (2021-2026) & (K Units) Table 120. Global Meropenem Injection Sales Market Share by Region (2021-2026) Table 121. Global Meropenem Injection Sales by Region (2027-2032) & (K Units) Table 122. Global Meropenem Injection Sales Market Share by Region (2027-2032) Table 123. Global Meropenem Injection Revenue by Region (2021-2026) & (US$ Million) Table 124. Global Meropenem Injection Revenue Market Share by Region (2021-2026) Table 125. Global Meropenem Injection Revenue by Region (2027-2032) & (US$ Million) Table 126. Global Meropenem Injection Revenue Market Share by Region (2027-2032) Table 127. North America Meropenem Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. North America Meropenem Injection Sales by Country (2021-2026) & (K Units) Table 129. North America Meropenem Injection Sales by Country (2027-2032) & (K Units) Table 130. North America Meropenem Injection Revenue by Country (2021-2026) & (US$ Million) Table 131. North America Meropenem Injection Revenue by Country (2027-2032) & (US$ Million) Table 132. Europe Meropenem Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Europe Meropenem Injection Sales by Country (2021-2026) & (K Units) Table 134. Europe Meropenem Injection Sales by Country (2027-2032) & (K Units) Table 135. Europe Meropenem Injection Revenue by Country (2021-2026) & (US$ Million) Table 136. Europe Meropenem Injection Revenue by Country (2027-2032) & (US$ Million) Table 137. Asia Pacific Meropenem Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Asia Pacific Meropenem Injection Sales by Country (2021-2026) & (K Units) Table 139. Asia Pacific Meropenem Injection Sales by Country (2027-2032) & (K Units) Table 140. Asia Pacific Meropenem Injection Revenue by Country (2021-2026) & (US$ Million) Table 141. Asia Pacific Meropenem Injection Revenue by Country (2027-2032) & (US$ Million) Table 142. South America Meropenem Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. South America Meropenem Injection Sales by Country (2021-2026) & (K Units) Table 144. South America Meropenem Injection Sales by Country (2027-2032) & (K Units) Table 145. South America Meropenem Injection Revenue by Country (2021-2026) & (US$ Million) Table 146. South America Meropenem Injection Revenue by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa Meropenem Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. Middle East and Africa Meropenem Injection Sales by Country (2021-2026) & (K Units) Table 149. Middle East and Africa Meropenem Injection Sales by Country (2027-2032) & (K Units) Table 150. Middle East and Africa Meropenem Injection Revenue by Country (2021-2026) & (US$ Million) Table 151. Middle East and Africa Meropenem Injection Revenue by Country (2027-2032) & (US$ Million) Table 152. Global Meropenem Injection Sales by Type (2021-2026) & (K Units) Table 153. Global Meropenem Injection Sales by Type (2027-2032) & (K Units) Table 154. Global Meropenem Injection Sales Market Share by Type (2021-2026) Table 155. Global Meropenem Injection Sales Market Share by Type (2027-2032) Table 156. Global Meropenem Injection Revenue by Type (2021-2026) & (US$ Million) Table 157. Global Meropenem Injection Revenue by Type (2027-2032) & (US$ Million) Table 158. Global Meropenem Injection Revenue Market Share by Type (2021-2026) Table 159. Global Meropenem Injection Revenue Market Share by Type (2027-2032) Table 160. Global Meropenem Injection Price by Type (2021-2026) & (US$/Unit) Table 161. Global Meropenem Injection Price by Type (2027-2032) & (US$/Unit) Table 162. Global Meropenem Injection Sales by Application (2021-2026) & (K Units) Table 163. Global Meropenem Injection Sales by Application (2027-2032) & (K Units) Table 164. Global Meropenem Injection Sales Market Share by Application (2021-2026) Table 165. Global Meropenem Injection Sales Market Share by Application (2027-2032) Table 166. Global Meropenem Injection Revenue by Application (2021-2026) & (US$ Million) Table 167. Global Meropenem Injection Revenue by Application (2027-2032) & (US$ Million) Table 168. Global Meropenem Injection Revenue Market Share by Application (2021-2026) Table 169. Global Meropenem Injection Revenue Market Share by Application (2027-2032) Table 170. Global Meropenem Injection Price by Application (2021-2026) & (US$/Unit) Table 171. Global Meropenem Injection Price by Application (2027-2032) & (US$/Unit) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Meropenem Injection Distributors List Table 175. Meropenem Injection Customers List Table 176. Meropenem Injection Industry Trends Table 177. Meropenem Injection Industry Drivers Table 178. Meropenem Injection Industry Restraints Table 179. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Meropenem Injection Product Image Figure 5. Global Meropenem Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Meropenem Injection Market Size (2021-2032) & (US$ Million) Figure 7. Global Meropenem Injection Sales (2021-2032) & (K Units) Figure 8. Global Meropenem Injection Average Price (US$/Unit) & (2021-2032) Figure 9. 0.25g/vial Product Image Figure 10. 0.5g/vial Product Image Figure 11. 1g/vial Product Image Figure 12. Hospital Product Image Figure 13. Clinics Product Image Figure 14. Others Product Image Figure 15. Global Meropenem Injection Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Meropenem Injection, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Meropenem Injection Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Meropenem Injection Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Meropenem Injection Sales by Region in 2025 Figure 21. Global Meropenem Injection Revenue by Region in 2025 Figure 22. North America Meropenem Injection Market Size by Country in 2025 Figure 23. North America Meropenem Injection Sales Market Share by Country (2021-2032) Figure 24. North America Meropenem Injection Revenue Market Share by Country (2021-2032) Figure 25. United States Meropenem Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Meropenem Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Meropenem Injection Market Size by Country in 2025 Figure 28. Europe Meropenem Injection Sales Market Share by Country (2021-2032) Figure 29. Europe Meropenem Injection Revenue Market Share by Country (2021-2032) Figure 30. Germany Meropenem Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Meropenem Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Meropenem Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Meropenem Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Netherlands Meropenem Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Nordic Countries Meropenem Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Asia Pacific Meropenem Injection Market Size by Country in 2025 Figure 37. Asia Pacific Meropenem Injection Sales Market Share by Country (2021-2032) Figure 38. Asia Pacific Meropenem Injection Revenue Market Share by Country (2021-2032) Figure 39. China Meropenem Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Japan Meropenem Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. South Korea Meropenem Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. India Meropenem Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Australia Meropenem Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. China Taiwan Meropenem Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Southeast Asia Meropenem Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Southeast Asia Meropenem Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South America Meropenem Injection Market Size by Country in 2025 Figure 48. South America Meropenem Injection Sales Market Share by Country (2021-2032) Figure 49. South America Meropenem Injection Revenue Market Share by Country (2021-2032) Figure 50. Mexico Meropenem Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Brazil Meropenem Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Argentina Meropenem Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Middle East and Africa Meropenem Injection Market Size by Country in 2025 Figure 54. Middle East and Africa Meropenem Injection Sales Market Share by Country (2021-2032) Figure 55. Middle East and Africa Meropenem Injection Revenue Market Share by Country (2021-2032) Figure 56. Turkey Meropenem Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Saudi Arabia Meropenem Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. UAE Meropenem Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Global Meropenem Injection Sales Market Share by Type (2021-2032) Figure 60. Global Meropenem Injection Revenue Market Share by Type (2021-2032) Figure 61. Global Meropenem Injection Price (US$/Unit) by Type (2021-2032) Figure 62. Global Meropenem Injection Sales Market Share by Application (2021-2032) Figure 63. Global Meropenem Injection Revenue Market Share by Application (2021-2032) Figure 64. Global Meropenem Injection Price (US$/Unit) by Application (2021-2032) Figure 65. Meropenem Injection Value Chain Figure 66. Meropenem Injection Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Meropenem Injection Industry Opportunities and Challenges

Scope & coverage.

Types
  • 0.25g/vial
  • 0.5g/vial
  • 1g/vial
Applications
  • Hospital
  • Clinics
  • Others
Companies covered
  • Chongqin Shenghuaxi
  • Zhejiang Hisun Pharmaceutical
  • Xinya Pharm
  • CSPC Group
  • Shenzhen Haibin Pharmaceutical
  • Sandoz
  • Mylan
  • Luoxin Pharmaceutical
  • United Laboratories
  • Pfizer
  • Hainan Haiyao Co., Ltd.
  • Fresenius Kabi
  • PKU HealthCare
  • Sumitomo Dainippon Pharma
  • Sagent Pharmaceuticals
  • Macleods Pharmaceuticals
  • Johnlee Pharmaceuticals
  • Bionova Scientific
  • AuroMedics
  • Amneal Pharmaceuticals

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Meropenem Injection Market Size (2021-2032)
  4. 2.2.2 Global Meropenem Injection Sales (2021-2032)
  5. 2.2.3 Global Meropenem Injection Market Average Price (2021-2032)
  6. 2.3 Meropenem Injection by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 0.25g/vial
  9. 2.3.3 0.5g/vial
  10. 2.3.4 1g/vial
  11. 2.4 Meropenem Injection by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Hospital
  14. 2.4.3 Clinics
  15. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Meropenem Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Meropenem Injection Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Meropenem Injection Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Meropenem Injection Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Meropenem Injection Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Meropenem Injection, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Meropenem Injection, Product Type & Application
  8. 3.8 Global Manufacturers of Meropenem Injection, Established Date
  9. 3.9 Global Meropenem Injection Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Chongqin Shenghuaxi
  2. 4.1.1 Chongqin Shenghuaxi Company Information
  3. 4.1.2 Chongqin Shenghuaxi Business Overview
  4. 4.1.3 Chongqin Shenghuaxi Meropenem Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Chongqin Shenghuaxi Meropenem Injection Product Portfolio
  6. 4.1.5 Chongqin Shenghuaxi Recent Developments
  7. 4.2 Zhejiang Hisun Pharmaceutical
  8. 4.2.1 Zhejiang Hisun Pharmaceutical Company Information
  9. 4.2.2 Zhejiang Hisun Pharmaceutical Business Overview
  10. 4.2.3 Zhejiang Hisun Pharmaceutical Meropenem Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Zhejiang Hisun Pharmaceutical Meropenem Injection Product Portfolio
  12. 4.2.5 Zhejiang Hisun Pharmaceutical Recent Developments
  13. 4.3 Xinya Pharm
  14. 4.3.1 Xinya Pharm Company Information
  15. 4.3.2 Xinya Pharm Business Overview
  16. 4.3.3 Xinya Pharm Meropenem Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Xinya Pharm Meropenem Injection Product Portfolio
  18. 4.3.5 Xinya Pharm Recent Developments
  19. 4.4 CSPC Group
  20. 4.4.1 CSPC Group Company Information
  21. 4.4.2 CSPC Group Business Overview
  22. 4.4.3 CSPC Group Meropenem Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 CSPC Group Meropenem Injection Product Portfolio
  24. 4.4.5 CSPC Group Recent Developments
  25. 4.5 Shenzhen Haibin Pharmaceutical
  26. 4.5.1 Shenzhen Haibin Pharmaceutical Company Information
  27. 4.5.2 Shenzhen Haibin Pharmaceutical Business Overview
  28. 4.5.3 Shenzhen Haibin Pharmaceutical Meropenem Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Shenzhen Haibin Pharmaceutical Meropenem Injection Product Portfolio
  30. 4.5.5 Shenzhen Haibin Pharmaceutical Recent Developments
  31. 4.6 Sandoz
  32. 4.6.1 Sandoz Company Information
  33. 4.6.2 Sandoz Business Overview
  34. 4.6.3 Sandoz Meropenem Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Sandoz Meropenem Injection Product Portfolio
  36. 4.6.5 Sandoz Recent Developments
  37. 4.7 Mylan
  38. 4.7.1 Mylan Company Information
  39. 4.7.2 Mylan Business Overview
  40. 4.7.3 Mylan Meropenem Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Mylan Meropenem Injection Product Portfolio
  42. 4.7.5 Mylan Recent Developments
  43. 4.8 Luoxin Pharmaceutical
  44. 4.8.1 Luoxin Pharmaceutical Company Information
  45. 4.8.2 Luoxin Pharmaceutical Business Overview
  46. 4.8.3 Luoxin Pharmaceutical Meropenem Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Luoxin Pharmaceutical Meropenem Injection Product Portfolio
  48. 4.8.5 Luoxin Pharmaceutical Recent Developments
  49. 4.9 United Laboratories
  50. 4.9.1 United Laboratories Company Information
  51. 4.9.2 United Laboratories Business Overview
  52. 4.9.3 United Laboratories Meropenem Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 United Laboratories Meropenem Injection Product Portfolio
  54. 4.9.5 United Laboratories Recent Developments
  55. 4.10 Pfizer
  56. 4.10.1 Pfizer Company Information
  57. 4.10.2 Pfizer Business Overview
  58. 4.10.3 Pfizer Meropenem Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Pfizer Meropenem Injection Product Portfolio
  60. 4.10.5 Pfizer Recent Developments
  61. 4.11 Hainan Haiyao Co., Ltd.
  62. 4.11.1 Hainan Haiyao Co., Ltd. Company Information
  63. 4.11.2 Hainan Haiyao Co., Ltd. Business Overview
  64. 4.11.3 Hainan Haiyao Co., Ltd. Meropenem Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Hainan Haiyao Co., Ltd. Meropenem Injection Product Portfolio
  66. 4.11.5 Hainan Haiyao Co., Ltd. Recent Developments
  67. 4.12 Fresenius Kabi
  68. 4.12.1 Fresenius Kabi Company Information
  69. 4.12.2 Fresenius Kabi Business Overview
  70. 4.12.3 Fresenius Kabi Meropenem Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Fresenius Kabi Meropenem Injection Product Portfolio
  72. 4.12.5 Fresenius Kabi Recent Developments
  73. 4.13 PKU HealthCare
  74. 4.13.1 PKU HealthCare Company Information
  75. 4.13.2 PKU HealthCare Business Overview
  76. 4.13.3 PKU HealthCare Meropenem Injection Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 PKU HealthCare Meropenem Injection Product Portfolio
  78. 4.13.5 PKU HealthCare Recent Developments
  79. 4.14 Sumitomo Dainippon Pharma
  80. 4.14.1 Sumitomo Dainippon Pharma Company Information
  81. 4.14.2 Sumitomo Dainippon Pharma Business Overview
  82. 4.14.3 Sumitomo Dainippon Pharma Meropenem Injection Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Sumitomo Dainippon Pharma Meropenem Injection Product Portfolio
  84. 4.14.5 Sumitomo Dainippon Pharma Recent Developments
  85. 4.15 Sagent Pharmaceuticals
  86. 4.15.1 Sagent Pharmaceuticals Company Information
  87. 4.15.2 Sagent Pharmaceuticals Business Overview
  88. 4.15.3 Sagent Pharmaceuticals Meropenem Injection Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Sagent Pharmaceuticals Meropenem Injection Product Portfolio
  90. 4.15.5 Sagent Pharmaceuticals Recent Developments
  91. 4.16 Macleods Pharmaceuticals
  92. 4.16.1 Macleods Pharmaceuticals Company Information
  93. 4.16.2 Macleods Pharmaceuticals Business Overview
  94. 4.16.3 Macleods Pharmaceuticals Meropenem Injection Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Macleods Pharmaceuticals Meropenem Injection Product Portfolio
  96. 4.16.5 Macleods Pharmaceuticals Recent Developments
  97. 4.17 Johnlee Pharmaceuticals
  98. 4.17.1 Johnlee Pharmaceuticals Company Information
  99. 4.17.2 Johnlee Pharmaceuticals Business Overview
  100. 4.17.3 Johnlee Pharmaceuticals Meropenem Injection Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Johnlee Pharmaceuticals Meropenem Injection Product Portfolio
  102. 4.17.5 Johnlee Pharmaceuticals Recent Developments
  103. 4.18 Bionova Scientific
  104. 4.18.1 Bionova Scientific Company Information
  105. 4.18.2 Bionova Scientific Business Overview
  106. 4.18.3 Bionova Scientific Meropenem Injection Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Bionova Scientific Meropenem Injection Product Portfolio
  108. 4.18.5 Bionova Scientific Recent Developments
  109. 4.19 AuroMedics
  110. 4.19.1 AuroMedics Company Information
  111. 4.19.2 AuroMedics Business Overview
  112. 4.19.3 AuroMedics Meropenem Injection Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 AuroMedics Meropenem Injection Product Portfolio
  114. 4.19.5 AuroMedics Recent Developments
  115. 4.20 Amneal Pharmaceuticals
  116. 4.20.1 Amneal Pharmaceuticals Company Information
  117. 4.20.2 Amneal Pharmaceuticals Business Overview
  118. 4.20.3 Amneal Pharmaceuticals Meropenem Injection Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Amneal Pharmaceuticals Meropenem Injection Product Portfolio
  120. 4.20.5 Amneal Pharmaceuticals Recent Developments
5 Global Meropenem Injection Market Scenario by Region
  1. 5.1 Global Meropenem Injection Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Meropenem Injection Sales by Region: 2021-2032
  3. 5.2.1 Global Meropenem Injection Sales by Region: 2021-2026
  4. 5.2.2 Global Meropenem Injection Sales by Region: 2027-2032
  5. 5.3 Global Meropenem Injection Revenue by Region: 2021-2032
  6. 5.3.1 Global Meropenem Injection Revenue by Region: 2021-2026
  7. 5.3.2 Global Meropenem Injection Revenue by Region: 2027-2032
  8. 5.4 North America Meropenem Injection Market Facts & Figures by Country
  9. 5.4.1 North America Meropenem Injection Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Meropenem Injection Sales by Country (2021-2032)
  11. 5.4.3 North America Meropenem Injection Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Meropenem Injection Market Facts & Figures by Country
  15. 5.5.1 Europe Meropenem Injection Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Meropenem Injection Sales by Country (2021-2032)
  17. 5.5.3 Europe Meropenem Injection Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.5.9 Nordic Countries
  24. 5.6 Asia Pacific Meropenem Injection Market Facts & Figures by Country
  25. 5.6.1 Asia Pacific Meropenem Injection Market Size by Country: 2021 VS 2025 VS 2032
  26. 5.6.2 Asia Pacific Meropenem Injection Sales by Country (2021-2032)
  27. 5.6.3 Asia Pacific Meropenem Injection Revenue by Country (2021-2032)
  28. 5.6.4 China
  29. 5.6.5 Japan
  30. 5.6.6 South Korea
  31. 5.6.7 India
  32. 5.6.8 Australia
  33. 5.6.9 China Taiwan
  34. 5.6.10 Southeast Asia
  35. 5.7 South America Meropenem Injection Market Facts & Figures by Country
  36. 5.7.1 South America Meropenem Injection Market Size by Country: 2021 VS 2025 VS 2032
  37. 5.7.2 South America Meropenem Injection Sales by Country (2021-2032)
  38. 5.7.3 South America Meropenem Injection Revenue by Country (2021-2032)
  39. 5.7.4 Mexico
  40. 5.7.5 Brazil
  41. 5.7.6 Argentina
  42. 5.8 Middle East and Africa Meropenem Injection Market Facts & Figures by Country
  43. 5.8.1 Middle East and Africa Meropenem Injection Market Size by Country: 2021 VS 2025 VS 2032
  44. 5.8.2 Middle East and Africa Meropenem Injection Sales by Country (2021-2032)
  45. 5.8.3 Middle East and Africa Meropenem Injection Revenue by Country (2021-2032)
  46. 5.8.4 Turkey
  47. 5.8.5 Saudi Arabia
  48. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Meropenem Injection Sales by Type (2021-2032)
  2. 6.1.1 Global Meropenem Injection Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Meropenem Injection Sales Market Share by Type (2021-2032)
  4. 6.2 Global Meropenem Injection Revenue by Type (2021-2032)
  5. 6.2.1 Global Meropenem Injection Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Meropenem Injection Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Meropenem Injection Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Meropenem Injection Sales by Application (2021-2032)
  2. 7.1.1 Global Meropenem Injection Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Meropenem Injection Sales Market Share by Application (2021-2032)
  4. 7.2 Global Meropenem Injection Revenue by Application (2021-2032)
  5. 7.2.1 Global Meropenem Injection Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Meropenem Injection Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Meropenem Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Meropenem Injection Value Chain Analysis
  2. 8.1.1 Meropenem Injection Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Meropenem Injection Production Mode & Process
  5. 8.2 Meropenem Injection Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Meropenem Injection Distributors
  8. 8.2.3 Meropenem Injection Customers
9 Global Meropenem Injection Analyzing Market Dynamics
  1. 9.1 Meropenem Injection Industry Trends
  2. 9.2 Meropenem Injection Industry Drivers
  3. 9.3 Meropenem Injection Industry Opportunities and Challenges
  4. 9.4 Meropenem Injection Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst